Glucose monitoring has long shaped as a high-potential application for wearable devices. These could one day come in the form of contact lenses that change color as glucose levels hit dangerous levels, or small biosensors that monitor bodily fluids and send alerts via a smartphone app instead.
Dexcom, developer of glucose monitoring products, has taken the latter approach, and that seems to gel well with Fitbit's vision for wearable computing. Dexcom's CGM (continuous glucose monitoring system) consists of a small sensor that measures levels just beneath the skin and transmits data wirelessly to a smartphone app.
But Dexcom and Fitbit have now joined forces to bring this data to the Ionic smartwatch. That means users of both Android and iOS devices will be able to have Dexcom's glucose data displayed on their wrist, beginning sometime in 2018.
"The strength of our brand and our ability to track critical health metrics continuously for up to 4-plus days, coupled with Dexcom's market leadership in CGM, present a powerful combination that we hope will help millions of people better manage their diabetes," says James Park, CEO of Fitbit. "With Ionic, we are focused on driving positive health outcomes and more health focused tools, and this collaboration is a wonderful example of how we plan to bring that vision to our users."
The Fitbit Ionic can be preordered for US$300, with shipping to kick off in October.
Want a cleaner, faster loading and ad free reading experience?
Try New Atlas Plus. Learn more